ViewRay’s MRIdian Is Promising, But Losses Mount
The company’s MRIdian offers more accurate radiotherapy for cancer patients but they won’t have the field to themselves. Worries about the viability of the MRIdian are unfounded as a competitor […]
The company’s MRIdian offers more accurate radiotherapy for cancer patients but they won’t have the field to themselves. Worries about the viability of the MRIdian are unfounded as a competitor […]
The company is enjoying multiple growth vectors pushing the shares higher as its home infusion solutions are a major cost saver for the healthcare system. It also sprouts an attractive […]
The company was already doing well but then it made a smart acquisition of Pointer Telocation, which is a larger company than PowerFleet itself. The acquisition will likely provide a […]
Akoustis has generated a fair amount of critics, skeptics and shorts, and until recently this was understandable, given years of promise and disappointment. However, the company is already selling commercially […]
While the company is making good progress, the shares have fallen back as perhaps it’s all going a little slower than investors hoped. But management is hitting the accelerator with […]
The sky seems to be clear for CEVA, with growth in most of its customer’s end markets all but assured. 5G drives demand for base stations, handsets, IoT and industry […]
The main question for investors is whether Zuora will be able to revive its slowing growth. There are promising signs of the subscription economy spreading to new industries and the […]
The company is growing fast on a number of innovative introductions like the B2B channel and checkout technology. These innovations not only boost growth, they have also further reduced customer […]
Perion’s shares have been on a tear on the basis of its booming search business, which is fast growing and very profitable. The shares still sell at very low multiples […]
SHU is positioning mostly in small-cap technology plays plus some turnaround stories which have their own dynamics and little correlation with market averages. The greatest risk for the market is […]